Abstract
A multicenter double-blind placebo-controlled trial was performed on aβ 2-adrenergic agonist, clenbuterol, in 165 women with stress incontinence. Clenbuterol remarkably improved the stress incontinence, and urodynamically the drug was found to increase the maximal urethral closure pressure. Some side effects were noted, but they were not serious. The results of this trial showed clenbuterol to be a promising drug for the treatment of stress incontinence.
Similar content being viewed by others
References
Andersson KE, Sjögren C. Aspects on the physiology and pharmacology of the bladder and urethra.Prog Neurobiol 1982;19:71–89
Khanna OP. Nonsurgical therapeutic modalities. In: Krane RJ, Siroky MB eds. Clinical neurourology. Boston: Little Brown and Company, 1978;178–179
Gleason DM, Reilly RJ, Bottacini MR et al. The urethral continence zone and its relation to stress incontinence.J Urol 1974;112:81–88
Kishimoto T, Aoki K, Okamiya Y et al. Effects of clenbuterol on resting tension and contractile response in vesicourethral smooth muscle of rabbits.Japan J Smooth Muscle Res 1989;25:13–25
Kishimoto T, Morita T, Okamiya Y et al. Effect of clenbuterol on contractile response in periurethral striated muscle of rabbits.Tohoku J Exp Med 1991;165:243–245
Grüneberger A, Geier G. Die Therapie der motorischen Reizblase mit demβ 2-Sympathomimetikum Clenbuterol.Urologe/ Ausg/A, 1981;20:153–154
Koch J, Günther KP, Steinberger H. Behandlung der Drangin-kontinenz mit Clenbuterol.Deutsche Medizin Wochenschr 1980;105:724–727
Lindholm P, Lose G. Terbutaline (Bricanyl) in the treatment of female urge incontinence.Urol Int 1986;41:158–160
Grünberger A. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.Br J Obstet Gynaecol 1984;91:275–278
Tammen H, Forster D. Wirksamkeit und Vertraglichkeit desβ 2-Adrenergikums Clenbuterol bei unfreiwilligem Harnabgang.Urologe [B] 1984;24:93–94
Shimazaki J, Yasuda K, Kawabe K, et al. Evaluation of clinical effects of clenbuterol on pollakisuria and incontinence.Nishinihon J Urol 1989;51:1745–1758
Morita T. Experimental studies for urinary incontinence: effect ofβ 2-agonist on the vesicourethral function.Japan J Urol 1989;80:1597–1604
Yamanishi T, Yasuda K, Nagashima K et al. Clinical effects of clenbuterol-HCl in urge incontinence and stress incontinence.Acta Urol Japan 1990;36:207–211
Yasuda K, Yamanishi T, Kamura K et al. Long-term use of clenbuterol tablets for incontinence, urinary urgency and frequency.Nishinihon J Urol 1990;51:2129–2137
Brown M, Wickham JEA. The urethral pressure profile.Br J Urol 1969;41:211–217
Jørgensen L, Lose G, Anderson JT. One-hour pad-weighing test for objective assessment of female urinary incontinence.Obstet Gynecol 1987;69:39–42
Ek A, Alm P, Andersson KE et al. Adrenoceptor and cholinoceptor-mediated response of the isolated human urethra.Scand J Urol Nephrol 1977;11:97–102
Bowman WC, Nott NW. Actions of sympathomimetic amines and their antagonists on skeletal muscle.Pharmacol Rev 1969;21:27–71
Fellenius E, Hedberg R, Holmberg E et al. Functional and metabolic effects of terbutaline and propranolol in fast- and slow-contracting skeletal muscle in vitro.Acta Physiol Scand 1980;109:89–95
Gosling JA, Dixon JS, Critchley HOD, Thompson S-A. A comparative study of the human external sphincter and periurethral levator ani muscle.Br J Urol 1981;53:35–41
Gjone R. Peripheral autonomic influence on the motility of the urinary bladder in the cat.Acta Physiol Scand 1965;66:81–90
Bors E. Effect of electric stimulation of the pudendal nerves on the vesical neck: its significance for the function of cord bladders: a preliminary report.J Urol 1952;67:925–935
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Yasuda, K., Kawabe, K., Takimoto, Y. et al. A double-blind clinical trial of a β2-adrenergic agonist in stress incontinence. Int Urogynecol J 4, 146–151 (1993). https://doi.org/10.1007/BF00571623
Issue Date:
DOI: https://doi.org/10.1007/BF00571623